In Tiruchy, a synthetic opioid called Tapentadol is pulling young people — some as young as seventeen — into a spiral of dependence that is doubling hospital admissions and seeding a quiet epidemic of Hepatitis C through shared needles. What was once a rare clinical encounter has become a monthly reality for doctors, a financial and emotional catastrophe for families, and a test of whether a city's institutions can respond swiftly enough to a crisis that is still accelerating. The story unfolding in this Tamil Nadu district is not merely a local health emergency; it is a mirror held up to the
Tiruchy's opioid crisis: Young users turn to injected Tapentadol amid health risks
Young people aged 17-30 are experiencing severe health complications including seizures, fainting episodes, vascular damage, and Hepatitis C infections; families report depression and behavioral crises.